Hands-on Courses - Additional Registration Fee Required

Hands-on Courses

103HO - MR US Fusion Guided Prostate Biospy: Integrating MP MRI and Biopsy into Your Urologic Practice for Screening, Diagnosis and Treatment Planning

Saturday, May 19
7:30 AM - 10:30 AM

Currently, MR imaging has undergone an expanding role in men with a clinical suspicion for or diagnosed with prostate cancer. The application of MR imaging to guide biopsies has been limited to radiologists until recently with the introduction of new MR/US fusion guided biopsy devices. This technological advance has allowed Urologists to move the MR-guided biopsy from the radiology practice to their offices.

It is paramount that urologists understand the basic fundamentals of prostate imaging and targeted biopsy techniques. The goal of this beginner course is to provide a hands on experience and an introduction to the technology, MR imaging, and the skills needed to perform a MR US fusion guided biopsy.

During the course, you will have the opportunity to ask questions and obtain tips and tricks from some of the leaders in the field who have help developed this new technology. We will review the basics of MR imaging, interpretation, co-registration, fusion technology, and the techniques of MR/US fusion-guided prostate biopsy for the three types of fusion technologies available. This includes computer-aided fusion, mechanical localization and electromagnetic tracking.

Learning Objectives:

Ardeshir R. Rastinehad

Icahn School of Medicine at Mount Sinai

Art Rastinehad, D.O. joined the faculty at Mount Sinai as Associate Professor of Radiology and Urology. He trained at the National Cancer Institute as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship trained in Urologic Oncology and Interventional Radiology. He has expertise in a wide array of interventional radiological and surgical techniques, including image guided procedures, laparoscopic and robotic surgery.

Dr. Rastinehad’s prostate cancer team has now incorporated state-of-the-art imaging to help visualize suspicious areas in the prostate for cancer. Dr. Rastinehad has also authored and implemented clinical trials of new techniques in the diagnosis and treatment of localized prostate cancer. Most recently, he is the principle investigator for a Phase III clinical trial using MRI/Ultrasound fusion technology to improve prostate biopsy techniques. Using information from the prostate MRI, we can now target specific areas to better diagnose and quantify a patient’s prostate cancer. This was the first trial of this technology in the United States outside the National Institutes of Health. This new clinical approach is helping to lay a foundation for the evaluation of a new technique, Focal Therapy, which only treats the diseased portion of the prostate. As of May 216, Dr Rastinehad was the first in the world to perform a gold nano-particle directed ablation using an transperineal MR US Fusion guided focal therapy system.

For more information, please visit www.interventionalurology.com

Dr. Rastinehad’s research has been published in leading national and international medical journals including The Journal of Urology, Journal of Radiology, Urology, and The British Journal of Urology. He has also authored several book chapters. He has also served as the course director for the first international course on MR US fusion guided prostate biopsies sponsored by the American Urological Association.

Presentation(s):

Send Email for Ardeshir Rastinehad

Peter A. Pinto

National Cancer Institute, National Institutes of Health

Presentation(s):

Send Email for Peter Pinto

Arvin K. George

University of Michigan

Arvin K. George, MD is a Urologic Surgeon specializing in the diagnosis and management of genitourinary cancers. After obtaining his medical degree from the Royal College of Surgeons in Ireland, he completed his Urology Residency at the Smith Institute for Urology, Hofstra North Shore-LIJ School of Medicine. He remained to complete his Endourology fellowship in New York gaining additional subspectialty expertise in robotic, laparoscopic, and percutaneous surgery. Subsequently, he completed a Urologic Oncology fellowship at the National Cancer Institute, National Institutes of Health. Dr. George’s clinical practice includes both surgical and non-operative management of prostate, kidney, ureteral, testicular, and bladder cancers. Dr. George’s research interests include minimally invasive and image-guided treatments, functional prostate imaging and focal therapy for prostate cancer.

Dr. George’s research focuses on the use of prostate MRI, MR/Ultrasound fusion-guided prostate biopsy, and focal therapy for prostate cancer including HIFU, Cryotherapy, and Laser ablation. His research aims to identify appropriate use for imaging in diagnosis, risk stratification, and management of prostate cancer including active surveillance and selection/treatment of patients with novel focal therapy modalities.

Presentation(s):

Send Email for Arvin George

Soroush Rais-Bahrami

University of Alabama at Birmingham

Dr. Soroush Rais-Bahrami is an Assistant Professor of Urology and Radiology at the University of Alabama at Birmingham as well as being a co-founder of the UAB Program for Personalized Prostate Cancer Care.
He received a Bachelor of Science in Biology and a Bachelor of Arts in Anthropology from the University of Maryland. He later received his Medical Degree from the Johns Hopkins University School of Medicine and then completed residency training in urologic surgery at the Arthur Smith Institute for Urology at the Hofstra North Shore-LIJ School of Medicine in New York. Following residency he further specialized in urologic oncology as a fellow at the National Cancer Institute of the National Institutes of Health.
Dr. Rais-Bahrami has a strong interest in the development and implementation of imaging for the diagnosis, staging, and treatment of urologic cancers as well as developing, improving, and employing robotic and minimally-invasive techniques for the treatment of urologic malignancies.

Presentation(s):

Send Email for Soroush Rais-Bahrami

Samir S. Taneja

NYU Langone Medical Center

Samir S. Taneja, M.D. is the James M. Neissa and Janet Riha Neissa Professor of Urologic Oncology, Professor of Urology and Radiology, and Director of the Division of Urologic Oncology in the Department of Urology at NYU Langone Health. He additionally oversees the Genitourinary Oncology Program in the Perlmutter Cancer Center. He has extensive experience in the diagnosis, evaluation, and surgical treatment of prostate cancer. He has been an innovator in the clinical application of pre-biopsy prostate MRI and techniques of MRI-targeted biopsy using MRI to ultrasound co-registration (fusion) techniques. He is also widely recognized as one of the most experienced innovators in the emerging field of prostate cancer focal therapy, having led and completed both single and multi-center clinical trials at NYULMC, and utilizing a wide spectrum of focal therapy energy sources including cryosurgery, HIFU, bipolar RFA, laser, and vascular-targeted photodynamic therapy. He has vast experience with robotic-assisted laparoscopic prostatectomy, drawing upon his open radical prostatectomy experience to develop his own techniques for nerve-sparing. Dr. Taneja is nationally renowned as a leader in the treatment and research of urologic cancers. He has served on the Society of Urologic Oncology Executive Committee, American Board of Urology Exam Committee, and is past Secretary General of the Urologic Research Society. Dr. Taneja has authored over 200 articles, 30 book chapters, 5 monographs, and 3 textbooks on urologic cancer or surgery, including the 3rd, 4th, and 5th editions of Taneja’s Complications of Urologic Surgery: Diagnosis, Prevention, and Management. He is on the editorial board of several journals, serves as the Consulting Editor of the Urologic Clinics of North America, and is the Urology Surveys prostate cancer contributor for the Journal of Urology. He regularly lectures across the world, having been an invited lecturer in 5 continents, and throughout the United States.

Presentation(s):

Send Email for Samir Taneja

Leonard S. Marks

UCLA

Dr. Marks is Professor and inaugural holder of the deKernion Chair in urology at the David Geffen School of Medicine at UCLA. He was graduated from the University of Texas, where he received the M.D. with AOA honors and Masters of Arts (Physiology) degrees in 1969. He served an internship and surgical residency at UCLA/Harbor General Hospital. For 2 years after that, he served on active duty as Lt. Cdr. in the U.S. Public Health Service. He was named a Post-Doctoral Research Scholar at UCLA School of Medicine in 1973-4. He completed his urology residency at UCLA and was Lecturer in Urology there in 1978, following which he entered private practice in Los Angeles. He re-joined the UCLA faculty full-time in 2009.

While in practice, Dr. Marks founded a non-profit research organization, Urological Sciences Research Foundation, a 501c3 corporation, to further his academic interests. He became an original AFUD scholar in 1992 for work relating serum PSA levels to prostate histology. He received a Prostate Cancer Foundation (PCF) research award in 2000 for cross-cultural studies of prostate cancer. An early advocate of multimedia in urology, he served as Website Editor of Urology (The Gold Journal) from 1998-2010. For his work in the scientific evaluation of alternative medicines, he was appointed to committees of the American Urological Association, the National Institutes of Health (NCCCAM and NIDDK), and the National Academy of Sciences.

He has for the past 7 years been Principle Investigator of three separate R01 Awards from the National Cancer Institute, devoted to targeted prostate biopsy and focal therapy. He has authored more than 160 scientific publications.

Presentation(s):

Send Email for Leonard Marks

Ashutosh K. Tewari

Icahn School of Medicine at Mount Sinai

Ashutosh (Ash) K. Tewari, MBBS, MCh, Chairman, Milton and Carroll Petrie Department of Urology, Mount Sinai Health System and Professor, Urology at the Icahn School of Medicine at Mount Sinai is a world-renowned urologist and prostate cancer specialist. As Director of the Department of Urology, he leads a multidisciplinary team committed to improving prostate cancer treatment, research and education. A pioneer of daVinci robotic surgery for prostate cancer, Dr. Tewari was part of the team that performed the first robotic radical prostatectomy in the United States and he has performed over 5,500 robotic radical prostatectomy surgeries to date. Importantly, he has refined the standard robotic surgical technique to improve cancer control and greatly decrease side effects, improving quality of life for his patients. At Mount Sinai, The Tewari Lab is working on unlocking the genomic causes of prostate cancer. Another goal of his research is to develop effective immunotherapy agents, personalized to a patient's own tumor and with increased ability to educate a patient's immune system to eliminate cancer. Dr. Tewari has been consecutively noted as a Castle Connolly and New York Magazine Top Doctor since 2006.

Presentation(s):

Send Email for Ashutosh Tewari

James S. Wysock

NYU School of Medicine

James S. Wysock, MD, MS, is an Assistant Professor in the Department of Urology at the NYU School of Medicine. Following a brief career as a research chemical engineer, he he received his medical degree from Northwestern University Feinberg School of Medicine.

He completed his surgical internship at New York Presbyterian Hospital in New York followed by his urology residency at the Brady Institute of Urology, Weill Cornell Medical School at New York Presbyterian Hospital. He then furthered his training in the Bruce Sherman Urologic Oncology Fellowship at NYU School of Medicine. During this time he also received his Masters Degree in Clinical Trial Design from the Clinical Translational Sciences Institute at NYU School of Medicine.

He currently works as an Assistant Professor of Urology at NYU School of Medicine, Department of Urology, where he focuses his clinical practice on the diagnosis and treatment of urologic oncology. He has a special research interest in advanced biopsy and treatment techniques for prostate cancer. He also serves as the Chief of service for Urology at Bellevue Hospital.

Presentation(s):

Send Email for James Wysock

Sara C. Lewis

Icahn School of Medicine at Mount Sinai

Dr. Sara Lewis MD is an Assistant Professor of Radiology in the Body Imaging/Body MRI Section at Icahn School of Medicine at Mount Sinai (ISMMS), New York. After finishing residency in Diagnostic Radiology at ISMMS where she also served as Chief Resident, Dr. Lewis then went on to complete an additional year of sub-specialization in abdominal MRI and CT. She subsequently joined the Body Imaging Section in 2011 and the Quantitative Imaging Research Lab (PI: Taouli) in TMII in 2016. Dr. Lewis is actively involved in multiple areas of clinical research in abdominal imaging. Her work is focused on conducting clinical translational imaging research centered on the use of advanced MRI methods in characterizing hepatobiliary neoplasms, renal transplant dysfunction and prostate cancer. Dr. Lewis has received grant support from SAR (2015) and RSNA (2016) for imaging research.

Dr. Lewis has authored and co-authored numerous peer-reviewed publications and actively lectures around the country. She is a peer reviewer for multiple peer-reviewed imaging journals and NIH/NCI. Dr. Lewis is also actively involved in radiology resident education, serving as a member of the Core Clinical Competency Committee and chair of the Program Evaluation Committee. She is a member of the Alpha Omega Alpha Medical Honor Society, Radiologic Society of North America, American Roentgen Ray Society and Society of Abdominal Radiology. She is board-certified by the American Board of Radiology in Diagnostic Radiology.

Presentation(s):

Send Email for Sara Lewis

Ismail Baris Turkbey

NCI, NIH

Dr. Turkbey obtained his medical degree from Hacettepe University in Ankara, Turkey in 2003. He completed his residency in Diagnostic and Interventional Radiology at Hacettepe University. He joined Molecular Imaging Program, National Cancer Institute, NIH in 2007. His main research areas are imaging of prostate cancer (multiparametric MRI, PET CT), prostate biopsy techniques, focal therapy for prostate cancer and image processing (segmentation, decision support systems).

Presentation(s):

Send Email for Ismail Baris Turkbey

Robert Villani

Zucker School of Medicine, Northwell Health

Robert Villani MD. Assistant professor of radiology, Zucker School of Medicine at Hofstra/Northwell, Northwell health. Fellowshiip trained body imager specializing in multiparametric prostate MRI and urologic radiology. Over 10 years of experience in the interpretation of multiparametric prostate MRI and co author of 7 papers on prostate cancer and multiparatmetric prostate magnetic resonance imaging .

Presentation(s):

Send Email for Robert Villani

Srinivas Vourganti

Rush University Medical Center

Dr. Srinivas Vourganti, MD is a board-certified urologic oncologist who serves as faculty at Rush University Medical Center in Chicago. He states: "Though it’s been an exciting time in the technical advancement of surgery, the science has yet to fully reach the patient’s bedside, and both overtreatment and undertreatment are rampant." It was a desire to address this need that drove him to complete a clinical and research fellowship at the NIH Urologic Oncology Branch of National Cancer Institute. There, he had the honor to collaborate with world experts in cancer care as well as leading basic scientists/engineers to develop new ideas to bring to the clinic. In addition to treating patients with complex cancers, there he spent three years developing innovative interventions focused on better and more certain diagnosis, and less invasive treatments.

As he continues his career at Rush University Medical Center in Chicago, he brings this experience to provide the highest quality, cutting-edge care to his patients while minimizing the impact that this treatment has on their quality of life. Dr. Vourganti is committed to limiting overtreatment of non-aggressive cancers. When appropriate, he prefers a strategy of active surveillance and careful integration of genetic testing in cancer care. Most importantly, he endeavors to continue his research to move the field forward.

Dr. Vourganti’s research has been widely published in leading peer-reviewed medical journals and he has authored several textbook chapters. He has been honored with numerous speaking invitations nationally and internationally. His expertise in the burgeoning field of imaging based prostate cancer diagnosis and treatment has been recognized and he has contributed as faculty in multiple hands-on courses in MR/US fusion guided prostate biopsy sponsored by the American Urological Association in order to contribute to the advancement of the greater Urologic community.

Presentation(s):

Send Email for Srinivas Vourganti

Osamu Ukimura

Kyoto PRefectural University of Medicine

1988-1989 Medical Residency, Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
1989-1993 Fellow in Urology, Kyoto Prefectural University of Medicine, Kyoto Japan
1993-1994 Vice-director, Nagoya Urological Hospital, Nagoya, Japan
1994-2004 Assistant Professor of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan
1995-1997 Visiting Assistant Professor of Urology, University of Texas, MD Anderson Cancer Center, Houston
2004-2006 Research Scholar of Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland
2006-2009 Associate Professor of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan
2009-2015 Clinical Professor of Urology, University of Southern California, Los Angeles (CA Medical Credential)
2015-present Professor & Chairman of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan

Presentation(s):

Send Email for Osamu Ukimura

Jonathan Coleman

Memorial Sloan Kettering Cancer Center

Dr Jonathan Coleman is an Associate Professor and urologic surgeon at Memorial Sloan Kettering Cancer Center in New York who specializes in minimally invasive and image guided treatment of cancers involving the upper urinary tract and prostate. His research is focused on genomic characterization of upper tract tumors and preclinical studies for the development of new therapies for upper tract and prostate cancer.

Presentation(s):

Send Email for Jonathan Coleman


Assets

103HO - MR US Fusion Guided Prostate Biospy: Integrating MP MRI and Biopsy into Your Urologic Practice for Screening, Diagnosis and Treatment Planning



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for MR US Fusion Guided Prostate Biospy: Integrating MP MRI and Biopsy into Your Urologic Practice for Screening, Diagnosis and Treatment Planning